data_1e8p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e8p _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.309 0.576 . . . . 4.5099999999999998 109.466 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.489 ' CB ' ' OD2' ' A' ' 41' ' ' ASP . 0.3 OUTLIER -154.93 25.1 0.43 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 2.5099999999999998 109.435 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.7 OUTLIER -43.68 103.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.92000000000000004 109.742 -179.988 -144.686 149.939 -123.176 103.992 2.017 103.728 -80.161 -47.783 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.656 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 5.8 p-90 -77.07 -23.69 51.94 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.268 -0.895 . . . . 0.26000000000000001 109.643 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.432 ' N ' ' CE3' ' A' ' 4' ' ' TRP . . . -63.74 -24.12 67.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 1.03 109.504 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.465 ' CG ' ' N ' ' A' ' 7' ' ' SER . 5.3 pt20 -51.46 -37.41 48.63 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.178 -0.951 . . . . 1.8700000000000001 109.77 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.465 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -44.47 -43.24 7.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 1.4299999999999999 109.721 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -89.38 -31.86 17.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 1.05 109.739 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.87 33.77 1.13 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.752 -1.214 . . . . 0.70999999999999996 110.194 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD2' ' HZ3' ' A' ' 30' ' ' TRP . 35.7 m-85 -103.32 163.13 12.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.095 -1.238 . . . . 2.1299999999999999 109.031 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -75.06 -150.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.132 -0.98 . . . . 1.8700000000000001 110.65 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.575 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 19.7 m -147.15 133.1 19.13 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.157 -0.683 . . . . 0.17999999999999999 109.157 -179.794 -47.783 -80.161 -123.176 103.728 2.017 103.992 149.939 -144.686 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.547 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 7.1 m -72.94 133.56 44.39 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.21 -0.931 . . . . 0.17999999999999999 110.426 -179.318 -43.312 -60.386 95.288 104.067 2.018 103.7 81.86 58.148 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -75.36 130.45 39.04 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.527 -0.916 . . . . 2.7400000000000002 108.527 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 57.7 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 1.8 108.661 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.507 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 34.8 Cg_endo -76.88 -30.81 4.33 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.804 2.336 . . . . 0.54000000000000004 110.837 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.7 p -77.95 17.01 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 1.79 109.972 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.4 m -151.2 16.99 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.996 -1.065 . . . . 1.76 109.923 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 19' ' ' THR . 1.4 m -117.97 98.07 6.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.051 -1.031 . . . . 1.05 109.487 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 22' ' ' GLU . 24.2 mtmt -43.89 118.0 1.33 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.349 -0.844 . . . . 2.9399999999999999 109.317 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 30' ' ' TRP . 29.7 t -68.04 123.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.528 -0.732 . . . . 1.0600000000000001 110.293 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.47 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -106.88 -20.64 13.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.131 -1.433 . . . . 1.5600000000000001 107.131 178.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.808 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.3 t80 -103.31 166.78 10.22 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.013 -0.736 . . . . 2.1499999999999999 109.013 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 1.2 m -170.65 110.4 0.36 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.23 -1.026 . . . . 1.0600000000000001 108.23 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.57 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 69.2 m-20 -150.7 -168.13 3.02 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.532 -0.867 . . . . 1.27 109.582 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.43 -6.86 8.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.971 . . . . 1.0800000000000001 108.44 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.656 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -87.85 4.81 43.15 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.81 0.814 . . . . 0.85999999999999999 109.01 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.59 -127.17 9.12 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.531 -1.828 . . . . 0.73999999999999999 108.531 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.681 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 49.5 mt-30 -130.55 146.67 52.12 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.756 -1.202 . . . . 1.8300000000000001 107.756 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.748 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -124.41 -176.32 3.48 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.877 -1.139 . . . . 0.17000000000000001 110.194 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -140.74 150.52 21.76 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.129 -1.988 . . . . 0.11 108.129 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.719 HG22 ' CH2' ' A' ' 37' ' ' TRP . 18.9 t -108.26 132.4 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.964 -1.316 . . . . 1.0600000000000001 109.427 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 60.7 mt-30 -151.22 132.29 14.34 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.554 -0.716 . . . . 1.8600000000000001 109.37 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.76 8.92 6.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.257 -0.902 . . . . 1.8899999999999999 109.324 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.94 24.85 54.39 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.39000000000000001 109.697 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 33' ' ' GLN . 10.9 pt20 -131.29 141.32 49.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.094 -1.239 . . . . 2.0299999999999998 109.818 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.808 ' CZ3' ' HB2' ' A' ' 23' ' ' TYR . 1.3 m95 -76.63 138.0 39.81 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.758 0.79 . . . . 0.17000000000000001 111.704 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.575 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 25.9 p -133.27 145.33 50.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.439 -0.948 . . . . 0.16 108.439 178.726 58.148 81.86 95.288 103.7 2.018 104.067 -60.386 -43.312 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.93 122.86 5.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.375 -1.09 . . . . 0.25 110.375 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 5.7 mt -89.95 118.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.352 -1.087 . . . . 1.0700000000000001 108.91 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.509 ' HB3' ' CB ' ' A' ' 44' ' ' TYR . 9.9 t0 -126.95 135.27 50.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.45 -0.781 . . . . 1.27 109.286 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.04 -23.59 61.4 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.219 -0.926 . . . . 2.25 109.527 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 m -90.13 -13.46 35.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.873 . . . . 1.5700000000000001 108.901 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.609 ' CG ' ' N ' ' A' ' 45' ' ' GLY . 4.8 t80 -73.71 165.57 24.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.426 -0.796 . . . . 2.1800000000000002 109.338 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.609 ' N ' ' CG ' ' A' ' 44' ' ' TYR . . . 85.08 21.42 55.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.407 . . . . 2.0600000000000001 109.581 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.187 -1.184 . . . . 5.9000000000000004 109.477 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.309 0.576 . . . . 4.0499999999999998 109.466 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.489 ' CB ' ' OD2' ' A' ' 41' ' ' ASP . 0.3 OUTLIER -154.93 25.1 0.43 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 2.1299999999999999 109.435 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.7 OUTLIER -43.68 103.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.92000000000000004 109.742 -179.988 -144.686 149.939 -123.176 103.992 2.017 103.728 -80.161 -47.783 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.656 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 5.8 p-90 -77.07 -23.69 51.94 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.268 -0.895 . . . . 0.26000000000000001 109.643 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -63.74 -24.12 67.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.17999999999999999 109.504 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.465 ' CG ' ' N ' ' A' ' 7' ' ' SER . 5.3 pt20 -51.46 -37.41 48.63 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.178 -0.951 . . . . 1.25 109.77 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.465 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -44.47 -43.24 7.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 1.1100000000000001 109.721 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -89.38 -31.86 17.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.87 109.739 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.87 33.77 1.13 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.752 -1.214 . . . . 0.70999999999999996 110.194 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.802 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 35.7 m-85 -103.32 163.13 12.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.095 -1.238 . . . . 1.21 109.031 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -75.06 -150.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.132 -0.98 . . . . 1.1200000000000001 110.65 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.59 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 19.7 m -147.15 133.1 19.13 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.157 -0.683 . . . . 0.17999999999999999 109.157 -179.794 -47.783 -80.161 -123.176 103.728 2.017 103.992 149.939 -144.686 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.547 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 7.1 m -72.94 133.56 44.39 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.21 -0.931 . . . . 0.17999999999999999 110.426 -179.318 -43.312 -60.386 95.288 104.067 2.018 103.7 81.86 58.148 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -75.36 130.45 39.04 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.527 -0.916 . . . . 2.1200000000000001 108.527 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 57.7 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 1.2 108.661 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 34.8 Cg_endo -76.88 -30.81 4.33 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.804 2.336 . . . . 0.46000000000000002 110.837 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.7 p -77.95 17.01 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 1.3400000000000001 109.972 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.4 m -151.2 16.99 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.996 -1.065 . . . . 1.3799999999999999 109.923 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 19' ' ' THR . 1.4 m -117.97 98.07 6.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.051 -1.031 . . . . 0.28000000000000003 109.487 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 22' ' ' GLU . 24.2 mtmt -43.89 118.0 1.33 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.349 -0.844 . . . . 2.5099999999999998 109.317 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.89 HG22 HD12 ' A' ' 40' ' ' ILE . 29.7 t -68.04 123.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.528 -0.732 . . . . 0.22 110.293 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -106.88 -20.64 13.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.131 -1.433 . . . . 1.5600000000000001 107.131 178.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.821 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.3 t80 -103.31 166.78 10.22 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.013 -0.736 . . . . 1.22 109.013 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.2 m -170.65 110.4 0.36 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.23 -1.026 . . . . 0.29999999999999999 108.23 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.57 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 69.2 m-20 -150.7 -168.13 3.02 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.532 -0.867 . . . . 1.27 109.582 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.43 -6.86 8.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.971 . . . . 0.22 108.44 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.656 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -87.85 4.81 43.15 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.81 0.814 . . . . 0.51000000000000001 109.01 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.59 -127.17 9.12 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.531 -1.828 . . . . 0.73999999999999999 108.531 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.696 ' HG2' HG23 ' A' ' 24' ' ' THR . 49.5 mt-30 -130.55 146.67 52.12 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.756 -1.202 . . . . 1.8300000000000001 107.756 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.755 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -124.41 -176.32 3.48 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.877 -1.139 . . . . 0.14000000000000001 110.194 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -140.74 150.52 21.76 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.129 -1.988 . . . . 0.11 108.129 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.025 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 18.9 t -108.26 132.4 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.964 -1.316 . . . . 0.20000000000000001 109.427 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 60.7 mt-30 -151.22 132.29 14.34 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.554 -0.716 . . . . 1.8600000000000001 109.37 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.76 8.92 6.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.257 -0.902 . . . . 1.8899999999999999 109.324 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.94 24.85 54.39 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.39000000000000001 109.697 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 33' ' ' GLN . 10.9 pt20 -131.29 141.32 49.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.094 -1.239 . . . . 1.3400000000000001 109.818 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 1.025 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -76.63 138.0 39.81 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.758 0.79 . . . . 0.17000000000000001 111.704 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.59 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 25.9 p -133.27 145.33 50.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.439 -0.948 . . . . 0.14999999999999999 108.439 178.726 58.148 81.86 95.288 103.7 2.018 104.067 -60.386 -43.312 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.93 122.86 5.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.375 -1.09 . . . . 0.25 110.375 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.89 HD12 HG22 ' A' ' 21' ' ' VAL . 5.7 mt -89.95 118.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.352 -1.087 . . . . 0.41999999999999998 108.91 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 9.9 t0 -126.95 135.27 50.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.45 -0.781 . . . . 1.27 109.286 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.04 -23.59 61.4 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.219 -0.926 . . . . 1.3400000000000001 109.527 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 m -90.13 -13.46 35.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.873 . . . . 1.1200000000000001 108.901 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.609 ' CG ' ' N ' ' A' ' 45' ' ' GLY . 4.8 t80 -73.71 165.57 24.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.426 -0.796 . . . . 1.27 109.338 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.609 ' N ' ' CG ' ' A' ' 44' ' ' TYR . . . 85.08 21.42 55.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.407 . . . . 2.0600000000000001 109.581 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.187 -1.184 . . . . 5.2599999999999998 109.477 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.309 0.576 . . . . 4.05 109.466 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.489 ' CB ' ' OD2' ' A' ' 41' ' ' ASP . 0.3 OUTLIER -154.93 25.1 0.43 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 2.13 109.435 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.7 OUTLIER -43.68 103.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.92 109.742 -179.988 -144.686 149.939 -123.176 103.992 2.017 103.728 -80.161 -47.783 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.656 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 5.8 p-90 -77.07 -23.69 51.94 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.268 -0.895 . . . . 0.26 109.643 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -63.74 -24.12 67.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.18 109.504 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.465 ' CG ' ' N ' ' A' ' 7' ' ' SER . 5.3 pt20 -51.46 -37.41 48.63 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.178 -0.951 . . . . 1.25 109.77 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.465 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -44.47 -43.24 7.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 1.11 109.721 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -89.38 -31.86 17.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.87 109.739 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.87 33.77 1.13 Allowed Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.752 -1.214 . . . . 0.71 110.194 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.802 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 35.7 m-85 -103.32 163.13 12.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.095 -1.238 . . . . 1.21 109.031 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -75.06 -150.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.132 -0.98 . . . . 1.12 110.65 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.59 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 19.7 m -147.15 133.1 19.13 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.157 -0.683 . . . . 0.18 109.157 -179.794 -47.783 -80.161 -123.176 103.728 2.017 103.992 149.939 -144.686 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.547 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 7.1 m -72.94 133.56 44.39 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.21 -0.931 . . . . 0.18 110.426 -179.318 -43.312 -60.386 95.288 104.067 2.018 103.7 81.86 58.148 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -75.36 130.45 39.04 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.527 -0.916 . . . . 2.12 108.527 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 57.7 93.15 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 1.2 108.661 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 34.8 Cg_endo -76.88 -30.81 4.33 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.804 2.336 . . . . 0.46 110.837 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.7 p -77.95 17.01 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 1.34 109.972 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.4 m -151.2 16.99 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.996 -1.065 . . . . 1.38 109.923 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 19' ' ' THR . 1.4 m -117.97 98.07 6.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.051 -1.031 . . . . 0.28 109.487 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 22' ' ' GLU . 24.2 mtmt -43.89 118.0 1.33 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.349 -0.844 . . . . 2.51 109.317 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.89 HG22 HD12 ' A' ' 40' ' ' ILE . 29.7 t -68.04 123.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.528 -0.732 . . . . 0.22 110.293 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -106.88 -20.64 13.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.131 -1.433 . . . . 1.56 107.131 178.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.821 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.3 t80 -103.31 166.78 10.22 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.013 -0.736 . . . . 1.22 109.013 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.696 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.2 m -170.65 110.4 0.36 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.23 -1.026 . . . . 0.3 108.23 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.57 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 69.2 m-20 -150.7 -168.13 3.02 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.532 -0.867 . . . . 1.27 109.582 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.43 -6.86 8.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.147 -0.971 . . . . 0.22 108.44 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.656 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -87.85 4.81 43.15 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.81 0.814 . . . . 0.51 109.01 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.59 -127.17 9.12 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.531 -1.828 . . . . 0.74 108.531 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.696 ' HG2' HG23 ' A' ' 24' ' ' THR . 49.5 mt-30 -130.55 146.67 52.12 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.756 -1.202 . . . . 1.83 107.756 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.755 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -124.41 -176.32 3.48 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.877 -1.139 . . . . 0.14 110.194 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -140.74 150.52 21.76 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.129 -1.988 . . . . 0.11 108.129 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.025 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 18.9 t -108.26 132.4 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.964 -1.316 . . . . 0.2 109.427 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 60.7 mt-30 -151.22 132.29 14.34 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.554 -0.716 . . . . 1.86 109.37 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.76 8.92 6.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.257 -0.902 . . . . 1.89 109.324 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.94 24.85 54.39 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.39 109.697 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 33' ' ' GLN . 10.9 pt20 -131.29 141.32 49.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.094 -1.239 . . . . 1.34 109.818 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 1.025 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -76.63 138.0 39.81 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.758 0.79 . . . . 0.17 111.704 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.59 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 25.9 p -133.27 145.33 50.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.439 -0.948 . . . . 0.15 108.439 178.726 58.148 81.86 95.288 103.7 2.018 104.067 -60.386 -43.312 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.93 122.86 5.96 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.375 -1.09 . . . . 0.25 110.375 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.89 HD12 HG22 ' A' ' 21' ' ' VAL . 5.7 mt -89.95 118.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.352 -1.087 . . . . 0.42 108.91 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 9.9 t0 -126.95 135.27 50.66 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.45 -0.781 . . . . 1.27 109.286 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.04 -23.59 61.4 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.219 -0.926 . . . . 1.34 109.527 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 m -90.13 -13.46 35.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.873 . . . . 1.12 108.901 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.609 ' CG ' ' N ' ' A' ' 45' ' ' GLY . 4.8 t80 -73.71 165.57 24.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.426 -0.796 . . . . 1.27 109.338 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.609 ' N ' ' CG ' ' A' ' 44' ' ' TYR . . . 85.08 21.42 55.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.407 . . . . 2.06 109.581 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.187 -1.184 . . . . 5.26 109.477 -179.998 . . . . . . . . 1 1 . 1 stop_ save_